Eva Rossmann

4PUBLICATIONS

74CO-AUTHORS

Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 17, 2026

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

|Nov 18, 2025

Cergutuzumab Amunaleukin in Combination with Atezolizumab in Patients with Carcinoembryonic Antigen-Positive Advanced/Metastatic Solid Tumors.

Ignacio Melero, Josep Tabernero, Neeltje Steeghs

|Feb 21, 2025

Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors.

Valentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz

|Feb 06, 2024

Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors.

Solange Peters, Eric Angevin, Teresa Alonso-Gordoa

Pageof 1

Frequent Collaborators

Christophe Boetsch

Solange Peters

Volker Teichgräber

Kristoffer S Rohrberg

Ignacio Melero

Jehad Charo

Stefan Evers

Josep Tabernero

Celine Adessi

David Dejardin

Frequent Collaborators

Christophe Boetsch

Solange Peters

Volker Teichgräber

Kristoffer S Rohrberg